Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
A. Benard, A. Jacobsen, M. Brunner, C. Krautz, B. Klosch, I. Swierzy, E. Naschberger, T. Birkholz, I. Castellanos, D. Trufa, H. Sirbu, M. Vetter, A. E. Kremer, K. Hildner, A. Hecker, , G. F. Weber
The paper finds that low interleukin-3 levels predict increased severity and mortality in SARS-CoV-2 infections and shows IL-3 promotes antiviral pDC recruitment.
bioRxiv · Jul 2, 2020Immunology